Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB00953_nanopub.RA_PGrPNsTcaaAjPu7I5kxtjdU1TCO9FwH2Qv2i7AtmbY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB00953 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00953 label "DDI between Zolmitriptan and Rizatriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and rizatriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. [drugbank_resource:DB00315_DB00953]" assertion.
- drugbank_resource:DB00315_DB00953 identifier "drugbank_resource:DB00315_DB00953" assertion.
- drugbank_resource:DB00315_DB00953 title "DDI between Zolmitriptan and Rizatriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and rizatriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated." assertion.
- drugbank:DB00953 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00953 assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00953 assertion.